For example, the NF-κB activators miR-301a and miR-30e* are overexpressed in pancreatic cancer and glioma, respectively[5,6]; the NF-κB inhibitor miR-195 is downregulated in HCC[9]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.